Advarra
Private Company
Funding information not available
Overview
Advarra is a major player in the digital health sector, specializing in clinical trial infrastructure and ethical oversight. Founded in 1983, it has evolved from a premier IRB provider into a comprehensive platform offering CTMS (OnCore, Clinical Conductor), eReg, eSource, and AI-powered study design via its Braid technology. The company serves a vast ecosystem, including 100% of the top 10 pharma sponsors and CROs, 88% of NCI-designated cancer centers, and over 3,500 institutions, positioning it as a critical enabler for modernizing and accelerating clinical research.
Technology Platform
Integrated clinical trial management ecosystem combining a leading Institutional Review Board (IRB) with CTMS (OnCore, Clinical Conductor), eReg, eSource, and the Braid AI-powered operational intelligence platform for study design, feasibility, and workflow automation.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Advarra competes in a fragmented but consolidating market. Key competitors include Veeva Systems (Veeva Vault CTMS), Medidata (Rave CTMS & EDC), Oracle Health (Clinical One), and smaller best-of-breed players in IRB, eReg, and site management. Its primary competitive advantage is the combination of its dominant, trusted IRB service with deeply embedded site operations software, creating a network effect that is difficult to replicate.